<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9419430" created="29/03/06" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9419430</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="agonistic_activity" sem="Other">Agonistic activity</term> of a <term id="T2" lex="CD40-specific_single-chain_Fv" sem="Protein_molecule">CD40-specific single-chain Fv</term> constructed from the <term id="T3" lex="variable_region" sem="Protein_domain_or_region">variable regions</term> of <term id="T4" lex="mAb_G28-5" sem="Protein_molecule">mAb G28-5</term>.</sentence>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">A <term id="T5" lex="single-chain_Fv" sem="Protein_molecule">single-chain Fv</term> (<term id="T6" lex="sFv" sem="Protein_molecule">sFv</term>) was expressed from the <term id="T7" lex="variable_region" sem="Protein_domain_or_region">variable regions</term> of the CD40-specific <term id="T8" lex="mAb_G28-5" sem="Protein_molecule">mAb G28-5</term>.</sentence>
<event id="E1">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>A single-chain Fv (sFv) was <clueType>expressed</clueType> from the variable regions of the CD40-specific mAb G28-5.</clue>
</event>
<sentence id="S3">The molecule bound <term id="T9" lex="CD40" sem="Protein_molecule">CD40</term> with a high affinity (2.2 nM) and was a monomer in solution.</sentence>
<event id="E2">
<type class="Binding"/>
<theme idref="T9"/>
<theme idref="T6"/>
<clue><corefCause>The molecule</corefCause> <clueType>bound</clueType> CD40 with a high affinity (2.2 nM) and was a monomer in solution.</clue>
</event>
<sentence id="S4">Surprisingly, <term id="T10" lex="G28-5_sFv" sem="Protein_molecule">G28-5 sFv</term> was a potent <term id="T11" lex="CD40_agonist" sem="Protein_family_or_group"><term id="T12" lex="CD40" sem="Protein_molecule">CD40</term> agonist</term> that rapidly crosslinked <term id="T13" lex="CD40" sem="Protein_molecule">CD40</term> on the <term id="T14" lex="cell_surface" sem="Cell_component">cell surface</term> but did not crosslink <term id="T15" lex="CD40-Ig" sem="Protein_complex"><term id="T16" lex="CD40" sem="Protein_molecule">CD40</term>-Ig</term> in solution.</sentence>
<event Manner="High" id="E4">
<type class="Binding"/>
<theme idref="T13"/>
<theme idref="T10"/>
<clue>Surprisingly, G28-5 sFv was a potent CD40 agonist that <clueManner>rapidly</clueManner> <clueType>crosslinked</clueType> CD40 <clueLoc>on the cell surface</clueLoc> but did not crosslink CD40-Ig in solution.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E5">
<type class="Binding"/>
<theme idref="T15"/>
<theme idref="T10"/>
<clue>Surprisingly, G28-5 sFv was a potent CD40 agonist that rapidly crosslinked CD40 on the cell surface but did <cluePolarity>not</cluePolarity> <clueType>crosslink</clueType> CD40-Ig <clueLoc>in solution</clueLoc>.</clue>
</event>
<sentence id="S5"><term id="T17" lex="G28-5_sFv" sem="Protein_molecule">G28-5 sFv</term> was a more potent agonist than <term id="T18" lex="G28-5_IgG" sem="Protein_molecule">G28-5 IgG</term> and was able to stimulate <term id="A2" sem="Other"><term id="T19" lex="CD40" sem="Protein_molecule">CD40</term> responses</term> by <term id="T20" lex="B_cell" sem="Cell_natural">B cells</term> and <term id="A1" sem="Cell_natural">monocytes</term>.</sentence>
<event CL="L2" KT="Analysis" id="E6">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="T17"/>
<clue>G28-5 sFv was a more potent agonist than G28-5 IgG and was <clueKT><clueCL>able</clueCL></clueKT> to <clueType>stimulate</clueType> CD40 responses by B cells and monocytes.</clue>
</event>
<event CL="L2" KT="Analysis" id="E7">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="T17"/>
<clue>G28-5 sFv was a more potent agonist than G28-5 IgG and was <clueKT><clueCL>able</clueCL></clueKT> to <clueType>stimulate</clueType> CD40 responses by B cells and monocytes.</clue>
</event>
<event KT="Other" id="E8">
<type class="Regulation"/>
<theme idref="T20"/>
<cause idref="T19"/>
<clue>G28-5 sFv was a more potent agonist than G28-5 IgG and was able to stimulate CD40 <clueType>responses</clueType> <linkTheme>by</linkTheme> B cells and monocytes.</clue>
</event>
<event KT="Other" id="E9">
<type class="Regulation"/>
<theme idref="A1"/>
<cause idref="T19"/>
<clue>G28-5 sFv was a more potent agonist than G28-5 IgG and was able to stimulate CD40 <clueType>responses</clueType> <linkTheme>by</linkTheme> B cells and monocytes.</clue>
</event>
<sentence id="S6"><term id="T21" lex="G28-5_IgG" sem="Protein_molecule">G28-5 IgG</term> partially blocked, whereas <term id="T22" lex="G28-5_sFv" sem="Protein_molecule">G28-5 sFv</term> augmented <term id="T23" lex="CD40_response" sem="Other"><term id="T24" lex="CD40" sem="Protein_molecule">CD40</term> responses</term> during stimulation with <term id="T25" lex="natural_ligand" sem="Protein_family_or_group">natural ligand</term> (<term id="T26" lex="gp39-CD8_fusion_protein" sem="Protein_molecule">gp39-CD8 fusion protein</term>).</sentence>
<event KT="Other" id="E13">
<type class="Positive_regulation"/>
<cause idref="T24"/>
<clue>G28-5 IgG partially blocked, whereas G28-5 sFv augmented CD40 <clueType>responses</clueType> during stimulation with natural ligand (gp39-CD8 fusion protein).</clue>
</event>
<event id="E10">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T21"/>
<clue>G28-5 IgG partially <clueType>blocked</clueType>, whereas G28-5 sFv augmented CD40 responses <clueExperiment>during stimulation with natural ligand (gp39-CD8 fusion protein)</clueExperiment>.</clue>
</event>
<event id="E11">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="T22"/>
<clue>G28-5 IgG partially blocked, whereas G28-5 sFv <clueType>augmented</clueType> CD40 responses <clueExperiment>during stimulation with natural ligand (gp39-CD8 fusion protein)</clueExperiment>.</clue>
</event>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="T24"/>
<cause idref="T26"/>
<clue>G28-5 IgG partially blocked, whereas G28-5 sFv augmented CD40 responses during <clueType>stimulation</clueType> <linkCause>with</linkCause> natural ligand (gp39-CD8 fusion protein).</clue>
</event>
<sentence id="S7">These results indicate that the <term id="T27" lex="functional_activity" sem="Other">functional activity</term> of ligands built from the <term id="T28" lex="binding_site" sem="Protein_domain_or_region">binding site</term> of <term id="T29" lex="G28-5" sem="Protein_molecule">G28-5</term> is highly dependent upon the size and physical properties of the molecule both in solution and on the <term id="T30" lex="cell_surface" sem="Cell_component">cell surfaces</term>.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
